@article{f488465f996c48939658f0b346de93fb,
title = "When is crossover desirable in cancer drug trials and when is it problematic?",
author = "A. Haslam and V. Prasad",
note = "Copyright: Copyright 2018 Elsevier B.V., All rights reserved.",
year = "2018",
month = may,
day = "1",
doi = "10.1093/annonc/mdy116",
language = "English",
volume = "29",
pages = "1080",
journal = "Annals of oncology : official journal of the European Society for Medical Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "5",
}